Friday, March 29, 2013

The Root of the Problem

Can the Supreme Court hike drug prices?
How the industry uses the high court to allow bribery, evade the FDA, and boost medicine prices 5 times their cost.
The Supreme Court oral arguments on marriage equality deserved all the attention they received — but it’s another case heard this week that will affect even more people over the course of their lifetimes. And it could cost Americans millions in prescription drug bills.
The case falls within a sadly predictable continuum for the Roberts Court, which virtually always sides with the corporate litigant over the government or individual. This time, the arguments in FTC v. Actavis revolve around an insidious tactic common to the nation’s largest drug companies, and known as “pay for delay.” As a result of the likely ruling in this case, drug companies will be able to charge consumers as much as five times the potential cost of their products. And both government regulators and consumers will watch helplessly as pharmaceutical companies bribe generic drug makers to retain their exclusive holds on the lifesaving medicines we all inevitably require.
If they spent as much time and money and cleverness on finding actual causes and cures...
Aah, never mind.

Related posts.